The observation that BRC-31 breast cancer cells exhibit preferential ERK2 activation and express markers of an EMT transition (E-cadherin and cytokeratin-8 low; N-cadherin, FN and vimentin high) prompted us to examine the phosphorylation status of FRA-1. This evidence concerns the gene CDH2 and breast cancer.